Global Biobanking Market Analysis and In-depth Research on Market Size Manufacturers,segments,user types

Biobanking refers to the process in which biological samples are collected and stored for research and clinical care. The major factors that contribute towards the market growth include rise in funding by private & government organizations for biobanking and increase in application areas of biobanked samples. Biobanked specimens are used in the treatment of several chronic diseases, and thus increase in incidence of disease such as cancer further supports the market growth. However, ethical issues related to biobanking and lack of awareness about it are expected to impede the market growth. Conversely, unmet medical needs in the emerging nations are expected to provide lucrative opportunity for the market.

Global biobanking market was valued at $47,062 million in 2017, and is estimated to reach $68,084 million by 2025, with a CAGR of 4.6% from 2018 to 2025. Biobanking is a procedure to collect and preserve biological materials that can be further used for diagnosis, biodiversity studies, and research. The major factors that drive the growth of the global biobanking market include rise in funding support by private & government organizations. Furthermore, increased incidence of chronic disease further propel the market growth. However, ethical and legal issues related to biobanking restrict the market growth.

Buy now and get FREE One Month Knowledge Tree Subscription (valid till 30 Nov'18):https://www.alliedmarketresearch.com/checkout/298812?utm_source=Prathm_OPR

Key Findings of the Biobanking Market:

• The research segment contributed for nearly two-thirds share of the global biobanking market in 2017.

• The private organization segment is projected to grow at a significant CAGR from 2018 to 2025.

• In 2017, national/regional agencies led the overall biobanking market, and is projected to grow at a CAGR of 4.2% during the forecast period.

• Germany and France are the major shareholders, which collectively accounted for more than one-third share of the Europe biobanking market in 2017.

• Japan is the major shareholder, accounting for more than one-third share of the Asia-Pacific biobanking market in 2017.

The blood product segment generated the maximum revenue in 2017, accounting for more than two-fifths share of the global biobanking market in 2017. On the other hand, solid tissue segment is expected to witness the highest CAGR during the forecast period.
By type of biobank, the disease-based biobank segment generated the maximum revenue in 2017 and population-based biobank segment is expected to grow at a CAGR of 5.2% during the forecast period.

Get sample copy of this report :
https://www.alliedmarketresearch.com/request-sample/2798?utm_source=Prathm_OPR

Europe market is projected to dominate the global biobanking market in terms of revenue during the forecast period. This is majorly due to the increase in number of biobanks in the region coupled with increasing research activities related to biobanking. On the other hand, the Asia-Pacific market is expected to grow at the highest CAGR of 5.7% during the forecast period.

Top key players :

• ASKION GmbH
• CTI BIOTECH
• Cureline Inc.
• Excilone SARL
• Firalis S.A.
• Hamilton Company
• LabVantage Solutions Inc.
• LGC Limited
• PrecisionMed Inc.
• ProMedDx LLC.

Send Enquiry on this report @
https://www.alliedmarketresearch.com/purchase-enquiry/2798?utm_source=Prathm_OPR

Chapter: 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. Top player positioning, 2017
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Rise in funds for biobanks
3.4.1.2. Increase in R&D activities for application of biobank specimens
3.4.1.3. Surge in prevalence of fatal chronic diseases

3.4.2. Restraints

3.4.2.1. Legal and ethical issues
3.4.2.2. Lack of awareness regarding biobanking

3.4.3. Opportunity

3.4.3.1. Untapped opportunities in the developing regions

3.4.4. Impact analyses

LIST OF TABLES

TABLE 01. BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 02. BLOOD PRODUCTS BIOBANKINGMARKET REVENUE FOR BLOOD PRODUCTS, BY REGION, 2017-2025 ($MILLION)
TABLE 03. BIOBANKING MARKET REVENUE FOR SOLID TISSUE, BY REGION, 2017-2025 ($MILLION)
TABLE 04. BIOBANKING MARKET REVENUE FOR CELL LINES, BY REGION, 2017-2025 ($MILLION)
TABLE 05. BIOBANKING MARKET REVENUE FOR OTHER SAMPLES, BY REGION, 2017-2025 ($MILLION)
TABLE 06. BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)
TABLE 07. POPULATION-BASED BIOBANKS MARKET REVENUE, BY REGION, 2017-2025 ($MILLION)
TABLE 08. DISEASE-ORIENTED BIOBANKS MARKET REVENUE, BY REGION, 2017-2025 ($MILLION)
TABLE 09. BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2017-2025 ($MILLION)
TABLE 10. BIOBANKING MARKET REVENUE FOR NATIONAL/REGIONAL AGENCY, BY REGION, 2017-2025 ($MILLION)
TABLE 11. BIOBANKING MARKET REVENUE FOR NONPROFIT ORGANIZATION, BY REGION, 2017-2025 ($MILLION)
TABLE 12. BIOBANKING MARKET REVENUE FOR UNIVERSITY, BY REGION, 2017-2025 ($MILLION)
TABLE 13. BIOBANKING MARKET REVENUE FOR PRIVATE ORGANIZATION, BY REGION, 2017-2025 ($MILLION)
TABLE 14. BIOBANKING MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 15. THERAPEUTIC BIOBANKING MARKET REVENUE, BY REGION, 2017-2025 ($MILLION)
TABLE 16. RESEARCH BIOBANKING MARKET REVENUE, BY REGION, 2017-2025 ($MILLION)
TABLE 17. BIOBANKING MARKET REVENUE, BY REGION, 2017-2025 ($MILLION)
TABLE 18. NORTH AMERICA BIOBANKING MARKET REVENUE, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 19. U.S. BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2017-2025 ($MILLION)
TABLE 20. U.S. BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2017-2025 ($MILLION)

Get Access to Full summary of this report at :
https://www.alliedmarketresearch.com/biobanking-market?utm_source=Prathm_OPR

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Deep Joshi
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.